Inspire (Nasdaq: ISPH) says it sold the 6 million of shares it offered beginning July 19 at $12 a share.

The 900,000 shares granted to the underwriters were also sold “in full”, the pharmaceutical company said.

Morgan Stanley, Deutsche Bank Securities, SG Cowen & Co., LLC and Piper Jaffray & Co. handled the sale.

In trading Friday, Inspire was selling at $13.29, up 79 cents.